Amerisource Health Services LLC recalls Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03,…
CGMP Deviations: recalling drug products following an FDA inspection.
Read the official notice →- Date
- 2023-05-31
- Country
- United States
- Brand
- Amerisource Health Services
- Product
- Glimepiride Tablets, USP, 4 mg, RX, Packaged as a) 100-count bottle, NDC# 68001-179-00; b) 500-count bottle, NDC# 68001-179-03,…
- Classification
- Class II
- Units
- Nationwide USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Amerisource Health Services recalls
- 2024-01-31
US
Amerisource Health Services LLC recalls Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health…
Superpotent drug: Assay results were slightly above specification at the time zero point.
- 2023-10-11
US
Amerisource Health Services LLC recalls HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health…
Failed Impurities/Degradation Specifications: Out of Specification results in the repackaged product for impurities at the 12-month time point.
- 2023-07-12
US
Amerisource Health Services LLC recalls Tizanidine Tablets, USP, 4 mg, 100 Tablets (10 tablets x 10 unit dose blister packs) per carton, Rx Only, Packaged and…
Failed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for dissolution.
- 2023-04-26
US
Amerisource Health Services LLC recalls Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by:…
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
- 2023-03-15
US
Amerisource Health Services LLC recalls Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by:…
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
- 2023-02-22
US
Amerisource Health Services LLC recalls BuPROPion Hydrochloride Tablets, USP 75 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging,…
Failed Impurities/Degradation Specifications
Other drugs & medical recalls in the United States
- 2023-05-31
US
US
SUN PHARMACEUTICAL INDUSTRIES INC recalls buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical…
Failed Dissolution Specifications; during stability testing
US
Alpha Aromatics recalls FOAMING HAND SANITIZER, fresh mint scent, 62% alcohol, 1 Gallon / 3.78 Liters bottle, 290 Alpha Drive RIDC industrial Park, Pittsburgh, PA…
CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.
US
Amneal Pharmaceuticals of New York, LLC recalls Methylprednisolone Acetate Injectable Suspension, USP 80 mg/mL, For Intramuscular, Intrasynovial and Soft Tissue…
Labeling: Not Elsewhere Classified; A typographical error was observed in the NDC number on the preprinted Individual Folding Cartons (secondary packaging only). Incorrect NDC Number 70121-1573-1; Correct NDC Number…
US
Central Admixture Pharmacy Services, Inc. recalls vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 mL per bag, Rx only, Central Admixture…
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
- 2023-05-24
US
Stryker Sustainability Solutions recalls REF 5065, Kendall, Impad Rigid Sole Foot Cover, Regular Pair ,<12", Rx Only Non-Sterile
Through complaint surveillance, it was identified that reprocessed Deep vein thrombosis (DVT) Compression Sleeves may be mislabeled and/or mispackaged.